Cancer-associated cachexia is a disorder characterized by loss of body weight with specific
losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination …

Cachexia, a systemic wasting condition, is considered a late consequence of diseases,
including cancer, organ failure, or infections, and contributes to significant morbidity and …

Many patients with cancer experience poor nutritional status, which detrimentally impacts
clinical outcomes. Poor nutritional status in cancer is primarily manifested by severe muscle …

Cancers are among the leading causes of morbidity and mortality worldwide, and the
number of new cases is expected to rise significantly over the next decades. At the same …

A variety of fatty acids exists in the diet of humans, in the bloodstream of humans, and in
cells and tissues of humans. Fatty acids are energy sources and membrane constituents …

EPA and DHA appear to be the most important n-3 fatty acids, but roles for n-3
docosapentaenoic acid are now also emerging. Intakes of EPA and DHA are usually low …

Purpose Existing definitions of clinically important weight loss (WL) in patients with cancer
are unclear and heterogeneous and do not consider current trends toward obesity. Methods …

To develop a framework for the definition and classification of cancer cachexia a panel of
experts participated in a formal consensus process, including focus groups and two Delphi …

Sarcopenia has recently emerged as a new condition that, independently from malnutrition,
may adversely affect the prognosis of cancer patients. Purpose of this narrative review is to …

Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life,
responsiveness to chemotherapy, and survival in advanced cancer patients. Our …